Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.9K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

4.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.4K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

238
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
238
Papillary Dermis01:11

Papillary Dermis

4.1K
Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen...
4.1K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

35
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
35
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staged approach to overcome hyperbilirubinemia: tailored chemotherapy in liver metastases-a case report.

Journal of gastrointestinal oncology·2026
Same author

An overview of KRAS-targeting therapies for colorectal cancer in phase I and II development.

Expert opinion on investigational drugs·2026
Same author

PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer.

bioRxiv : the preprint server for biology·2025
Same author

Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma.

bioRxiv : the preprint server for biology·2025
Same author

An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors.

International journal of molecular sciences·2025
Same author

XPO1 inhibition in KRAS-mutant cancers: time for clinical trials but how?

Translational lung cancer research·2025

Related Experiment Video

Updated: Oct 12, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.5K

Palpable lesions resistant to corticosteroids.

Muhammad Wasif Saif1, Richard Cagna2, Harold T Yamase3

  • 1Hermatology-OncoIogy, National Cancer Institute, National Institutes of Health, Bethesda, Md.

Patient Care
|November 19, 2021
PubMed
Summary
This summary is machine-generated.

This case study examines a woman with treatment-resistant leukocytoclastic vasculitis affecting the buttocks and waist. It details her symptoms and explores potential therapeutic strategies beyond standard prednisone treatment.

More Related Videos

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

264
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

330

Related Experiment Videos

Last Updated: Oct 12, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.5K
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

264
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

330

Area of Science:

  • Dermatology
  • Immunology
  • Internal Medicine

Background:

  • Leukocytoclastic vasculitis (LCV) is a small-vessel vasculitis often presenting with palpable purpura.
  • Corticosteroid resistance is a significant challenge in managing LCV, necessitating alternative treatment approaches.
  • The distribution of lesions on the buttocks, waist, and sock line suggests specific patterns of cutaneous involvement.

Purpose of the Study:

  • To present a case of leukocytoclastic vasculitis resistant to prednisone therapy.
  • To detail the clinical presentation and diagnostic considerations for this patient.
  • To discuss and evaluate various alternative treatment options for refractory LCV.

Main Methods:

  • Detailed clinical case report.
  • Review of patient's medical history and previous treatments.
  • Discussion of differential diagnoses and therapeutic strategies for LCV.

Main Results:

  • The patient exhibited persistent LCV lesions despite initial prednisone treatment.
  • Specific lesion locations (buttocks, waist, sock line) were noted.
  • A range of alternative treatments were considered and discussed.

Conclusions:

  • Prednisone resistance in LCV highlights the need for individualized treatment plans.
  • Exploring alternative immunosuppressants and targeted therapies is crucial for refractory cases.
  • Further research into novel treatment modalities for LCV is warranted.